Terlipressin-Associated Complete Heart Block.

IF 0.6 Q4 GASTROENTEROLOGY & HEPATOLOGY

ACG Case Reports Journal Pub Date : 2025-04-03 eCollection Date: 2025-04-01 DOI:10.14309/crj.0000000000001654

Jiunn Song, Tristan Alfie, E Kevin Heist, Raymond T Chung

引用次数: 0

Abstract

Terlipressin has been recently approved in the United States to treat hepatorenal syndrome, a feared complication of both acute and chronic liver diseases. Side effects of the medication have been studied through clinical trials and the precedent use in Europe, as well as extrapolation from its analog vasopressin. As its use is becoming more prevalent, unforeseen complications have arisen. We report a case of complete heart block associated with terlipressin use in presumed hepatorenal syndrome in acute liver injury.

查看原文本刊更多论文

特利加压相关的完全性心脏传导阻滞。

特立加压素最近在美国被批准用于治疗肝肾综合征，这是一种急性和慢性肝病的可怕并发症。该药物的副作用已经通过临床试验和欧洲的先例使用进行了研究，并从其类似物抗利尿激素进行了推断。随着它的使用越来越普遍，出现了无法预料的并发症。我们报告一例完全性心脏传导阻滞与特利加压素在急性肝损伤推定肝肾综合征中的应用有关。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

ACG Case Reports Journal GASTROENTEROLOGY & HEPATOLOGY-

自引率

14.30%

发文量

170

审稿时长

12 weeks

期刊介绍： ACG Case Reports Journal is a peer-reviewed, open-access publication that provides GI and hepatology fellows, private practice clinicians, and other healthcare providers an opportunity to share interesting case reports with their peers and with leaders in the field. ACG Case Reports Journal publishes case reports, images, videos and letters to the editor in all topics of gastroenterology and hepatology, including: Biliary Colon Endoscopy Esophagus Functional Bowel Disorders Inflammatory Bowel Disease Liver Nutrition and Obesity Pancreas Pathology Pediatric Small Bowel Stomach.